Amid its new thyroid API launch, Bioiberica was highlighting that it is seeking to develop further products for both the pharma and nutraceutical markets, but its searching for partners to galvanize this plan. Speaking at CPhI Worldwide 2019, Jaime Reguant, Healthcare Director also notes that the key market demands now are low dosages and clinical backing.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement














